Legend Biotech and Noile-Immune Biotech Announce Collaborative Research and Licensing Agreement Read more
Glenmark Initiates Phase 3 Clinical Trials on Antiviral Favipiravir for COVID-19 Patients in India Read more
Seattle Genetics gets approval of TUKYSA in Switzerland for metastatic HER2-positive breast cancer Read more
Moderna Receives FDA Fast Track Designation for mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Read more
Sarclisa (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myeloma Read more
Ocular Therapeutix Announces First Patient Dosed in Phase 1 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Read more
Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse Inhaled Nitric Oxide Therapy to Treat COVID-19 Read more
Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France Read more
CRISPR and Vertex announce FDA RMAT designation granted to CTX001 to treat severe hemoglobinopathies Read more